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Summary.-When L2C leukaemic B lymphocytes from guinea-pigs were incubated
in vitro with antibody directed to their surface immunoglobulin (Ig), a rapid rise in
intracellular adenosine 3':5'-phosphate (cyclic adenosine monophosphate, cAMP) was
observed. Estimation of cAMP was by a protein-binding assay using bovine adrenal
protein kinase. Increases up to 30-fold occurred within 30 seconds of incubation at
37°C, to be succeeded by a fall which reached the basal level between 5 and 7 min. The
response was proportional to the amount of antibody present. Cross-linking of
surface Ig by the antibody was necessary, bivalent (Fab'y)2 from the antibody gave a
rise in cAMP similar to that given by the parent molecule, whereas monomeric
Fab'y was ineffective unless it was subsequently cross-linked by anti-antibody. The
rise was too rapid to have required capping of the surface Ig for its induction. Not all
perturbations of the plasma membrane by antibody induce such a surge in cAMP,
since anti-/2 microglobulin, also reacting with the lymphocyte surface, failed to alter
cAMP concentration. The results emphasize that immunotherapy can be influenced
by antibody altering the metabolic activity of target cells, quite apart from activation
of immunological cytotoxic pathways.
FOLLOWING an initial study by Gorer
(1942) there have been many reports that
passively administered antibody can re-
tard or ablate experimental lymphoid
leukaemias and lymphomas (Motta, 1971;
Hersey, 1973; Zighelboim et al., 1974;
O'Neill, 1976; Johnson et al., 1977). The
mechanisms involved are difficult to
delineate, and present discussion (re-
viewed by Rosenberg & Terry, 1977)
relies heavily upon simplified systems in
which antibodies attack target cells in
vitro with the recruitment of ancillary
effectors: complement, K cells or macro-
phages. Much less attention has been paid
to the effects of antibody alone, since this
has long been known not to be frankly
cytotoxic for nucleated target cells (Ross
& Lepow, 1960). However, more subtle
effects on normal and neoplastic lymphoid
cells due to antibody alone have been
recorded, such as altered motility and
various metabolic changes (Unanue et
al., 1974; Nishizawa et al., 1977; Shearer
& Parker, 1978). Furthermore, antibody
has been reported to augment the sus-
ceptibility of neoplastic cells in vitro to
X-rays and some cytotoxic drugs (Rubens
et al., 1975).
We have been studying leukaemias of
B lymphocytes in man and guinea-pig,
with particular regard to the tumour-
specific antigens represented by idiotypic
determinants on surface immunoglobulin
(Ig) (Stevenson & Stevenson, 1975; Hough
et al., 1976). Passive anti-idiotype in
vivo retards guinea-pig leukaemia (Steven-
son et al., 1977). For studies in vitro
anti-Ig is used in the form of either
anti-idiotype or the more readily available
antibodies to constant determinants on
the surface Ig.
Here we report that antibody alone,
acting on the surface Ig of guinea-pig
leukaemic lymphocytes, causes a rapid and
dramatic rise in adenosine 3': 5'-phosphate
(adenosine cyclic monophosphate, cAMP).
A signal is thereby transmitted to the cellCYCLIC AMP IN LEUKAEMIC LYMPHOCYTES
which could initiate metabolic changes
with important implications for immuno-
therapy.
MATERIALS AND METHODS
Cells.-L2C lymphocytic leukaemia cells
were obtained from a line provided in
December 1972 by Dr E. Shevach of the
National Institutes of Health, Bethesda, Md,
U.S.A. A colony of Strain 2 guinea-pigs bred
from animals supplied by the National Insti-
tutes of Health was used for passaging the
cells in vivo. Blood from near-terminal
animals was obtained by cardiac puncture
and L2C cells were separated as described
previously (Stevenson et al., 1975). Such pre-
parations contain L2C cells of >95% viability
as judged by trypan-blue exclusion and <2%
contaminating cells. The cells exhibit surface
TgM, of light-chain class A, with -50,000
monomeric IgM molecules per cell in the
plasma membrane and no significant direct
export of the Ig (Hough et al., 1978).
Immunoqlobulins and antibodies.-Antisera
to guinea-pig Fab'y were raised in sheep as
described by Stevenson et al. (1975). Such
antisera are polyspecific for guinea-pig Ig
classes by virtue of reactivity against light-
chain determinants, and react with the sur-
face IgM of L2C cells via its A chains. To
obtain purified antibody, IgG from anti-
serum was passed through Sepharose 4B
(Pharmacia) to which normal guinea-pig IgG
had been coupled by the cyanogen bromide
method of Axen et al. (1967). The antibody
was eluted with 0-5M NH40H and dialysed
immediately against cold 0-2M Tris Buffer at
pH 8. Some contaminating aggregates were
removed by passage through an AcA 34
(L'industrie Biologique Francaise) column.
The reactivity towards cell-surface immuno-
globulin was determined by direct immuno-
fluorescence and its specificity for Ig was
demonstrated by blocking the reactivity with
purified guinea-pig Ig.
Fab'y and (Fab'Y)2 fragments weire pre-
pared from the above purified antibody by
peptic digestion, respectively with or without
subsequent reduction (Stevenson et al., 1975).
Residual IgG was removed from the (Fab'Y)2
by passage through Sepharose 4B conjugated
to rabbit anti-sheep Fcy.
Purified antibody from sheep anti-guinea-
pig 92-microglobulin was a gift from F. K.
Stevenson (Stevenson et al., 1978). Its
specificity was confirmed by the fact that its
reaction with lymphocytic surfaces, assessed
by direct immunofluorescence, was blocked
by purified guinea-pig f2-microglobulin
(kindly supplied by I. Bergghrd, University
ofLund, Sweden).
IgG from normal sheep sera was passed
through Sepharose 4B conjugated to guinea-
pig serum globulins to remove any natural
antibody activity against guinea-pig Ig.
Antisera were raised in rabbits to normal
sheep IgG by conventional means (Stevenson
et al., 1975). After preparation of rabbit IgG
from the antisera, natural antibody activity
to guinea-pig globulins was removed as
described above.
Cell cultures and extracts.-Cell suspensions
(5 X 107/ml) were incubated with antibody at
37TC, normally in Eagle's minimal essential
medium supplemented with 1% non-essential
amino acids and 0.03% glutamine (supple-
mented MEM). The reaction was terminated
by chilling rapidly in an ice bath. When intra-
cellular cAMP levels were required, cultures
were centrifuged at 4°C and the pellets only
used. To determine total cAMP in a culture
it was necessary to carry out the incubation
in Dulbecco's medium to avoid materials
interfering with the cAMP assay. In each case
cell lysates were prepared by acidification
(with HC1 to 0-1m or perchloric acid to 1%)
and heating at 80TC for 5 min.
Estimation of cAMP.-Lysates were
neutralized with Tris or KHCO3 and assayed
by the protein-binding assay of Brown et al.
(1971). The cAMP -binding protein, protein
kinase from bovine adrenal cortex, was
obtained from BDH Biochemicals (Poole,
U.K.), and [3H]-cAMP from the Radiochemi-
cal Centre (Amersham, U.K.). Other chemi-
cals, including cAMP, were obtained from
Sigma (London). All assays were in duplicate,
giving ranges normally within 10% of the
mean.
Authentication of cAMP assay.-Inter-
ference from other nucleotides was found to
be minimal: ATP did not interfere when
present in the assay at 100 ,kM, while 3': 5'-
cCMP, 3': 5'-cIMP and 3': 5'-cGMP gave 50%
inhibition of [3H]-cAMP binding at 20 zM,
1-4 /tM and 1-0 uM respectively. Identity of
the nucleotide assayed was established by the
phosphodiesterase treatment described by
Watson (1976). Finally, assays on cAMP
separated from cell extracts by sequential
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chromatography on Dowex 1 and thin-layer
cellulose (XVatson, 1976) agreed within 20%
with assays on the crude extracts
RESULTS
Basal levels of cAMP in L2C cells
cAMP was estimated in cells freshly
prepared and after incubation at 5 x 107
cells/ml in supplemented MEM at 37°C for
up to 60 min. Values between 3 and 4
pmol/107 cells were obtained with no
significant change occurring during incu-
bation.
Antibody-indatced changes in cAMP levels
When L2C cells were incubated with
antibody reacting with their surface Ig,
a sharp, short-lived increase in the intra-
cellular cAMP was seen. At 37°C the
interaction resulted in a surge in the cAMP
level which reached a peak within 30
seconds, followed by a rapid decline (Fig.
1). Incubations of cells from the same
preparation at lower temperatures, exem-
plified in Fig. 1 by that at 25TC, showed
quantitatively similar cAMP changes but
over a longer period.
Experiments to demonstrate the dose-
dependence of the antibody-induced rise
in cAMP were carried out by adding
varying amounts of antibody to the cells
in Dulbecco's medium at 0°-2°C and then
raising the temperature to 37TC. This
device slowed the attainment ofmaximum
cAMP concentrations and facilitated ac-
curate measurements of the maxima.
Total cAMP contents of the cultures were
determined. As shown in Fig. 2, cAMP
levels attained were a function ofantibody
concentration in the range studied.
When L2C cells were incubated in
Dulbecco's medium as described above
and only the culture fluid assayed, no
significant amount of cAMP was detected.
Furthermore, when total culture cAMP
and intracellular cAMP were estimated in
parallel experiments as described in
Materials and Methods, identical values
were obtained. This suggests that cAMP
is degraded intracellularly after its in-
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Fir. 1.-I vitro cAAMP response in L2C cells
on interaction with sheep anti-guinea-pig
Fab'y. 5 x 107 cells/ml in supplementedl
MEM were incubated with ] mg/ml JgG ex
sheep anti-guinea-pig Fab'y at 37°C
(U * *) or at 25°C (0 -- ). Cells
were equilibraited at the tenmperature ofinicuba-
tion prior to addition of the antibody.
A- - -A: 5 X 107 cells/ml incubated at 25°C
or 37 C without antibody. Each point
represents the mean of assay duplicates,
which usually agree(l within 10o%. The
range shown for the incubations at 25°C
comes from 2 experiments.
crease, with little if any being exported
from the cells.
Requirementfor multivalency ofantibody
(Fab'y)2 and Fab'y fragments prepared
from sheep anti-guinea-pig Fab'y were
tested in experiments similar to those
described above for the whole antibody
molecule. Whereas the response induced
by (Fab'y)2 is comparable to that given
by the whole antibody, Fab'y failed to
stimulate a significant response in L2C
cells (Fig. 3). The requirement for cross-
linking of the surface Ig was confirmed by
a double-antibody technique (Fig. 4).
When Fab'y-coated L2C cells were in-
cubated with rabbit anti-sheep IgG (1
mg/ml) at 37°C, there was a surge in
cAMP levels similar to that observed
previously with the bivalent antibody.
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FIG. 2.-Dose-dependence of cAMP response
in L2C cells. Average values of 3 estima-
tions are plotted (s.e.:. 10% mean). L2C
cells were cultured (5 x 107 cells/ml) with
antibody at different concentrations in
Dulbecco's medium. After addition of anti-
body at 0°-2°C, the cultures were brought
to 37°C for desired intervals, then chilled
and HCI was added to a final molarity of
0-1. The cultures were heated at 80'C for
5 min and total cAMP was estimated.
cultures contained sheep anti-guinea-pig
Fab'y at 500 ,ug/ml, * *; 125 ,ug/ml,
* 0; or 60 ,ug/ml, V- t. Control
samples contained normal sheep IgG
(absorbed with guinea-pig globulin) at 500
,ug/ml: A A.
Effect of antibody to another surface
constituent
Purified sheep antibody to guinea-pig
/32-microglobulin, which was shown by
immunofluorescence to react with the
surface of L2C cells, gave no rise in the
level of intracellular cAMP; neither upon
incubation with the antibody alone at
concentrations ranging from 2'5 to 400
,g/ml, nor in double-antibody incubations
with rabbit anti-sheep IgG also present.
Two types ofdouble-antibody incubations
were in fact carried out. In experiments
Antibody Concentration ( X 108 M)
FIG. 3.-Effect of antibody fragments on
cAMP response in L2C cells. Antibody con-
centrations are in terms of antibody sites
(2 per 150,000 mol. wt for IgG, 2 per
100,000 for (Fab'y)2, and 1 per 50,000 for
Fab'y). Cells were cultured at 5fx 107/ml
in supplemented MEM with doubling
dilutions of IgG ex purified sheep anti-
guinea-pig Fab'y (* ), (Fab'y)2
fragment (S 0*) or Fab'y fragment
(V V) derived from the same anti-
body. After addition at 0°-2°C, cultures
were brought to 37°C for 1-5 min. cAMP
was extracted from the cell pellet in 0lM
HCI and assayed. Control incubations
(----A) contained normal sheep IgG
absorbed with guinea-pig globulins. Aver-
age values of 2 estimations are plotted.
with sequential addition, incubation oc-
curred at 00C with sheep anti-guinea-pig
32-microglobulin (0.4mg/ml), the antibody
was removed by centrifugation, and
finally rabbit anti-sheep IgG was added
at 1 mg/ml and the temperature raised to
3700 for times ranging from 0 5 to 10 min.
Alternatively, the cells were preincubated
(00, 30 min) with 0.1 mg/ml or 0 4 mg/ml
of the sheep antibody to guinea-pig
32-microglobulin and the rabbit anti-sheep
IgG (1 mg/ml) was added without the
removal of the first antibody. In neither
of these cases was there a significant
change in cAMP levels. Parallel cultures,
in which cells from the same preparation
were exposed to anti-Ig (sheep anti-
guinea-pig Fab'y present at 0-5 mg/ml),
gave the usual sharp increase in cAMP
both in the presence and absence of the
second antibody (present at 1 mg/ml).
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FIG. 4.-Requirement for bivalency in the
antibody-induced cAMP response of L2C
cells. The cells were first incubated (0°C,
45 min) with Fab'y fragment (0 3 mg/ml)
derived from sheep IgG antibody to
guinea-pig Fab'y. The cells were then har-
vested by centrifugation (500 g, 4°C) and
resuspended in cold supplemented MEM
prior to incubation at 37°C in the absence
(A A) or presence ( 0) of 1 mg/
ml of rabbit antibody to sheep IgG. The
range shown for the incubations in the
presence ofthe second antibody comes from
2 experiments. The rabbit antibody alone
had no effect on uncoated cells nor on cells
preincubated in the presence of normal
sheep IgG.
Effect of inhibitors of prostaglandin
synthesis on the cAMP increase
Neither acetyl salicylic acid nor indo-
methacin had any effect on the antibody-
mediated rise in cAMP when present at
up to 25 ,ug/ml in the incubation medium.
DISCUSSION
The interaction of bivalent antibody
with the surface Ig of L2C leukaemic
lymphocyteB has consistently provoked a
dramatic surge in the level of intracellular
cAMP. The requirement for antibody
bivalence indicates that cross-linking of
the surface Ig is required. The time needed
to reach the cAMP maximum is similar
to that required for patching, the earliest
visible redistribution of surface Ig pro-
voked by anti-Ig (Schreiner & Unanue,
1976). It seems to be too early for capping
or appreciable endocytosis ofthe antibody-
surface Ig complexes to have occurred.
Both the rapidity of the reaction and its
independence ofinhibitorsofprostaglandin
synthesis distinguish it from a prosta-
glandin-dependent rise in cAMP described
by Skelly et al. (1978) in normal spleen
cells.
The dependence ofthe cAMP maximum
on antibody concentration could reflect
either the number of Ig receptors reacting
or the tightness of cross-linking. It is
noteworthy from our results with anti-
132-microglobulin that a rise in cAMP is
not an invariable sequel of bivalent anti-
body attaching to the cell surface, even
if cross-linking be enhanced by anti-
antibody forming a second layer. Ash
et al. (1977) have reported that some
membrane proteins, including Ig, form
transmembrane linkages to actin and
myosin upon being cross-linked. Whether
thisisnecessaryfortheactivationofadenyl
cyclase, and consequent rise in cAMP,
remains to be determined. Earp et al.
(1977) have detected by fluorescence
microscopy an association between surface
Ig patches and submembranous cAMP in
normal lymphocytes. It is difficult to
relate thislocalizedandprolonged accumu-
lation of cAMP to the transient surge in
total cellular cAMP found by us. Mechan-
isms responsible for the rapid subsidence
of raised cAMP levels, among which
activation ofphosphodiesterase appears to
be important, have been discussed by
d'Armiento et al. (1972).
The second messenger concept (Robison
et al., 1971) states that a rise in cAMP
leads to a variety of secondary metabolic
effects. The significance of such effects in
the present case has two facets: t4ey
might mimic physiological stimulation of
normal B lymphocytes, and they might
influence survival of neoplastic lympho-
cytes subjected to attack by antibody.
Schreiner & Unanue (1976) have re-
viewed the various metabolic changes
which follow the action of anti-Ig on
normal B lymphocytes. Such changes are
of particular interest if they provide clues
to the activation of B cells by antigen or
their regulation by anti-idiotype. It is
difficult, however, to extrapolate the
present findings with leukaemic B lym-
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phocytes to their normal analogues: the
latter are usually not mitotically active,
are difficult to isolate in pure culture,
and appear highly dependent upon inter-
actions with macrophages and T lympho-
cytes for their normal physiological
responses.
The major significance we attach to our
findings is that antibody can alter the
behaviour of neoplastic cells in ways
unrelated to recruitment of immuno-
logical killing mechanisms and varying
with the precise molecular target on the
cell surface. Antibody acting on neoplastic
lymphocytes in vitro has previously been
reported to yield a number of effects with
evident implications for serotherapy in
vivo: enhanced calcium uptake (Shearer
et al., 1976), inhibition of migration
(Cochran et at., 1973), and enhanced
nucleoside uptake and mitosis (Shearer &
Parker, 1978). Anti-Ig itself has been
shown to inhibit migration in vitro by
guinea-pig and human leukaemic lympho-
cytes (Stevenson & Stevenson, 1975;
Hough et al., 1976). It will be of interest
to determine whether any of these longer-
term effects are mediated via cyclic nucleo-
tide mechanisms. Such metabolic data
could also be relevant to the synergism
reported to exist sometimes between
antibody and drugs (Rubens et al., 1975).
Finally, direct metabolic effects of anti-
body could have a role in the well known
phenomenon of tumour enhancement, the
stimulation of growth in vivo by antibody
(e.g. Yutoku et al., 1974): this is often
attributed to antibody blocking a cell-
mediated attack on the tumour cells, but
a direct stimulatory effect by the antibody
might sometimes be more important.
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